Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06529614

An In-situ Detection for MicroRNA

We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–75 year

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy without serious diseases

-

Exclusion criteria

  • situations that may affect the results

Treatment and study plan

In-situ detection for Micro-RNA

Other

a new in-situ detection methods for Micro-RNA

Primary outcomes

  1. Sensitivity and specificity of test

    Time frame: 8 months

Study contacts

Contact information is provided by the study sponsor or research team.

Lei Dou, Dr.

CONTACT

[email protected]

15171473498

Sponsors and collaborators

Lead sponsor

Tongji Hospital

Other

Registry information

Official study title

A New Detection Method for MicroRNA in Patients With Breast Cancer

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 31, 2024
Registry last updated
Oct 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.